Randomized controlled trials involving liver failure.

Area of Science:

• Hepatology
• Clinical Research
• Evidence Synthesis

Background:

• Liver failure is a critical condition requiring effective treatment strategies.
• Randomized controlled trials (RCTs) are crucial for establishing evidence-based interventions.
• Recent advancements necessitate a review of the latest RCTs in liver failure management.

Purpose of the Study:

• To systematically analyze and summarize evidence from recent randomized controlled trials (RCTs) on liver failure.
• To identify trends in liver failure research, including geographical distribution and study themes.
• To assess the current state of evidence for various liver failure treatment modalities.

Main Methods:

• A comprehensive MEDLINE search was conducted to identify prospective RCTs published after 1996.
• Eligible RCTs were analyzed based on publication year, geographical location, and research focus.
• Sixty-two relevant RCTs were included in the review.

Main Results:

• The number of RCTs on liver failure has ranged from one to nine annually.
• Europe led in trial conduct (41), followed by Asia (11) and North America (10).
• Hepatic encephalopathy (26), esophageal variceal bleeding (17), and acute liver failure/artificial liver (13) were the most frequent study themes.

Conclusions:

• Therapeutic consensus appears established for managing variceal bleeding, ascites, and nutritional supplementation in liver failure.
• Significant evidence gaps remain, particularly concerning the efficacy of artificial liver support systems.
• Further high-quality RCTs are needed to advance treatment options for specific liver failure complications.